Ceapro Inc (CRPOF) 0.5643 $CRPOF
Ceapro Enters into Financing Agreement with Agriculture Financial Services Corporation
Marketwired - Thu Dec 18, 7:36AM CST
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company"

, a growth-stage biotechnology company focused on the development and commercialization of active ingredients for health care and cosmetic industries, announced today that it has signed an Offer Letter with Agriculture Financial Services Corporation (AFSC) for a commercial financing of up to $900,000.
CZO.VN: 0.640 (+0.040)
Ceapro Awarded Research Grant from Alberta Innovates Bio Solutions to Develop Novel Formulations for Energy Drink
Marketwired - Thu Dec 04, 7:06AM CST
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company"

, a growth-stage biotechnology company focused on the development and commercialization of active ingredients for health care and cosmetic industries, announced today that it has been awarded a non-reimbursable grant of $198,000 by Alberta Innovates Bio Solutions (AI Bio) to develop the Company's proprietary Beta Glucan formulation in combination with certain bioactives, for use in an energy drink. The AI Bio grant will support a collaborative research project being conducted with Professor Feral Temelli, Ph.D., at the Department of Agricultural, Food & Nutritional Science at the University of Alberta.
CZO.VN: 0.640 (+0.040)
Ceapro's Research Scientist, Bernhard Seifried, Ph.D., Honored with Scientific Achievement & Innovation Award from BioAlberta
Marketwired - Wed Nov 26, 10:01AM CST
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company"

, a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today that Bernhard Seifried, Ph.D., Senior Research Scientist at the Company, was recognized as the recipient of the Achievement Award for Scientific Achievement & Innovation at the BioAlberta 15th Annual General Meeting and Awards Gala in Calgary, Canada on November 25. The BioAlberta Scientific Achievement & Innovation award honors scientists and entrepreneurs who have demonstrated leadership and made significant, extensive and tangible contributions to the Alberta and Canadian life science community.
CZO.VN: 0.640 (+0.040)
Ceapro Appoints World Renowned Health and Disease Management Expert, William W. Li, M.D. to Board of Directors
Marketwired - Thu Nov 20, 7:36AM CST
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company"

, a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today the Company has appointed international health and disease management expert, William W. Li, M.D., to its Board of Directors.
CZO.VN: 0.640 (+0.040)
Ceapro Inc. Reports Third Quarter 2014 Financial Results
Marketwired - Fri Nov 14, 7:06AM CST
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company"

, a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today its financial results for the third quarter and nine-months ended September 30, 2014.
CZO.VN: 0.640 (+0.040)
Ceapro Engages Jenene Thomas Communications, LLC as Strategic Investor Relations and Corporate Communications Advisor
Marketwired - Thu Nov 13, 10:03AM CST
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company"

, a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today the Company has engaged Jenene Thomas Communications, LLC to provide strategic investor relations and communication advisory services.
CZO.VN: 0.640 (+0.040)
Ceapro Announces Change of Chairman of the Board
Marketwire - Fri Oct 03, 2:00PM CDT
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company"

, a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today the Company's Chairman, Edward A. Taylor has resigned, effective immediately.
CZO.VN: 0.640 (+0.040)
Ceapro Reports Record Second Quarter 2014 Financial Results
Marketwire - Wed Jul 30, 6:02AM CDT
Ceapro Inc. (TSX VENTURE: CZO) -
CZO.VN: 0.640 (+0.040)
Ceapro Receives BIOTECanada Gold Leaf Award
Marketwire - Tue Jun 24, 9:15PM CDT
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or the "Company"

today received a prestigious Gold Leaf Award as a recognition from its peers for its innovative work in the Canadian Industry and Agriculture market segment. The award was received in the presence of Alberta Premier, the Honourable Dave Hancock, and President & CEO of Novo Nordisk Canada, Mr. Vince Lamanna, during the BIO International Convention being held in San Diego.
NVO: 43.80 (+1.08), CZO.VN: 0.640 (+0.040)
Ceapro Announces Re-Election of Board Members at its Annual Meeting of Shareholders
Marketwire - Fri Jun 20, 3:01PM CDT
Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or "the Company"

announces that all Directors, Edward Taylor, Don Oborowsky, Gilles Gagnon, Glenn Rourke and John Zupancic, were re-elected to serve for another year at its annual meeting of shareholders held on June 11, 2014.
CZO.VN: 0.640 (+0.040)